` AGH (Althea Group Holdings Ltd) vs S&P/ASX 300 Comparison - Alpha Spread

AGH
vs
S
S&P/ASX 300

Over the past 12 months, AGH has underperformed S&P/ASX 300, delivering a return of -41% compared to the S&P/ASX 300's +7% growth.

Stocks Performance
AGH vs S&P/ASX 300

Loading
AGH
S&P/ASX 300
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
AGH vs S&P/ASX 300

Loading
AGH
S&P/ASX 300
Difference
www.alphaspread.com

Performance By Year
AGH vs S&P/ASX 300

Loading
AGH
S&P/ASX 300
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Althea Group Holdings Ltd vs Peers

S&P/ASX 300
AGH
LLY
JNJ
ROG
AZN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Althea Group Holdings Ltd
Glance View

Market Cap
20m AUD
Industry
Pharmaceuticals

Althea Group Holdings Ltd. is an investment company. The company is headquartered in Melbourne, Victoria. The company went IPO on 2018-09-21. The firm operates through three segments: Australia, United Kingdom and Canada. Australia segment provides technology platform, which is comprised of its on-the-ground Medical Science Liaison team and Althea Concierge, which reduces application times for healthcare professionals prescribed its medicinal cannabis products. The firm distribution and sale of Cannabis 2.0 products including edibles, topicals, and beverages through its subsidiary, Peak Processing Solutions.

AGH Intrinsic Value
0.04 AUD
Undervaluation 49%
Intrinsic Value
Price
Back to Top